Core Viewpoint - The deadline for the 2025 Global Aesthetic Technology Innovation Awards has been extended to May 26, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical aesthetics field [1][2]. Group 1: Event Details - The event will take place on June 12, 2025, at the Beijing Zhongguancun Exhibition Center, with an expected attendance of 500 participants from various sectors including government, hospitals, and investment institutions [1]. - The conference will gather clinical experts, top scientists, technology innovators, and regulatory bodies to discuss cutting-edge developments, commercialization paths, regulatory trends, and market opportunities in the medical aesthetics industry [1][3]. Group 2: Award Categories - The awards include the 2025 Global Aesthetic Technology Innovation Award, aimed at companies and manufacturers that have made significant technological innovations in medical aesthetics [5]. - The 2025 Global Aesthetic Clinical Excellence Award recognizes products or technologies that have achieved notable results in clinical applications, receiving positive feedback from both doctors and patients [6]. - The 2025 Global Aesthetic Industry Service Award honors companies and institutions providing exceptional services in areas such as technology innovation, clinical trials, and production [7]. - The 2025 Global Aesthetic Innovation & Translation Award is for individuals who have made outstanding contributions to innovation in medical aesthetics, promoting products or solutions with industrialization potential [8]. Group 3: Evaluation Process - The evaluation will be conducted through expert reviews and meetings [9]. - The submission phase is open until May 26, 2025, followed by a review and selection process from May 27 to June 2, 2025, with winners notified between June 3 and June 6, 2025 [12].

Core Viewpoint - The Global Cardiovascular Conference 2025 highlighted the latest advancements in cardiovascular technology innovation, emphasizing the importance of clinical-driven and industry collaboration for the growth of the cardiovascular device sector [1][10][71]. Group 1: Conference Overview - The conference was held on May 15, 2025, in Beijing, gathering over 600 professionals from clinical, research, industry, and investment sectors to discuss cardiovascular technology innovation and enterprise growth paths [1]. - The event featured the release of the "2025 Global Cardiovascular Innovation Annual White Paper," which presented the latest development patterns in the cardiovascular device market [10]. Group 2: Awards and Recognition - The conference awarded three major prizes: the "2025 Global Cardiovascular Technology Innovation Award," the "2025 Global Cardiovascular Clinical Application Award," and the "2025 Global Cardiovascular International Cooperation Award," recognizing outstanding contributions in technology breakthroughs and clinical applications [13][14]. - A total of 10 companies received the technology innovation award, while 7 companies were recognized for clinical applications, and 4 units received the international cooperation award [13][14]. Group 3: Policy and Support - The Haidian District government expressed strong support for cardiovascular medical technology as a strategic direction, aiming to promote the market reach of cardiovascular devices [5]. - Beijing's policy support will focus on enhancing "clinical-driven + industry collaboration" mechanisms to facilitate innovation and results transformation in the cardiovascular field [7]. Group 4: Clinical and Engineering Collaboration - Experts emphasized the need for deep collaboration between clinical practitioners and engineers to address clinical pain points and drive innovation in cardiovascular devices [17][23]. - The conference featured discussions on the evolution of coronary intervention techniques and the importance of integrating clinical needs into device development [20][23]. Group 5: Investment Insights - The cardiovascular device sector is entering a critical window where companies with original technologies and systematic compliance capabilities will be highly valued by capital and policy [50]. - Early-stage companies face challenges in selecting the right market segments, while mid-stage companies must navigate structural adjustments and new payment logic to survive [51]. Group 6: Market Education and Product Strategy - The importance of educating the market on new surgical techniques and fostering collaboration between clinicians and engineers was highlighted as essential for successful product adoption [69]. - Companies are encouraged to build a product matrix that supports long-term growth and resilience against market fluctuations [63]. Group 7: Future Outlook - The conference served as a starting point for further discussions on how to leverage original technologies and promote Chinese innovations on the global stage [71][72]. - The cardiovascular industry is poised for transformation, driven by policy changes and technological advancements, necessitating a focus on clinical value and collaborative innovation [71].

Core Insights - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation [1] - It highlights the "Medical Device Innovation and Engineering Transformation Workshop" organized by Shanghai Jiao Tong University, which aims to merge medical needs with engineering solutions [1][3] Course Highlights - Participants will learn to integrate medical pain points with engineering technology to create innovative medical products [3] - The workshop will cover the complete path from concept to market for medical devices, utilizing the Biodesign innovation methodology [3][7] - Attendees will have the opportunity to network with professionals from various fields, including doctors, engineers, and investors [3][8] Training Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University, with a fee of 8999 yuan per person [3][12] - The program includes high-intensity practical training over two days, focusing on medical innovation and technology layout [4][8] Course Structure - Day one will focus on medical innovation, technology layout, and practical exercises to foster collaboration among participants [4][6] - Day two will address the industrialization of innovations and funding pathways, including insights into medical device financing and government support policies [8][12] Expert Faculty - The faculty includes leading experts from Shanghai Jiao Tong University with extensive experience in medical technology and investment [9][10] - Notable faculty members have backgrounds in medical chip research, nanobiomedicine, and investment in high-tech medical companies [9][10] Networking Opportunities - The workshop will facilitate deep exchanges among cross-disciplinary experts, enhancing collaboration between technology and market needs [8][11] - Participants will have the chance to showcase their projects and receive feedback from mentors, potentially leading to investment and collaboration opportunities [11][12]

Core Viewpoint - The medical technology industry is at a crossroads of breakthrough and reconstruction, with advancements in AI-assisted diagnosis, high-end smart medical devices, innovative medical materials, and regenerative medicine reshaping disease discovery, treatment, and management [1]. Group 1: Conference Overview - The Second Global MedTech Conference will be held on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, aiming to promote the collaborative development of the global medical technology industry chain, innovation chain, and clinical applications [1][4]. - The first conference, Global MedTech Conference 2024, was organized by Siyu [2]. Group 2: Awards and Recognition - The conference will present several awards to recognize breakthroughs in medical technology, including the 2025 Global MedTech Innovation Award and the 2025 Global MedTech Clinical Application Award [3][7]. - The awards aim to honor cutting-edge technological advancements, successful results transformation, and outstanding services in the medical technology field [3]. Group 3: Conference Agenda - Proposed agenda topics include analysis of global medical technology development trends and policy environments, research and transformation paths for imaging platforms, new consumables, brain-computer interfaces, interventional devices, and diagnostic equipment [5]. - Other topics will cover the intersection of engineering and medicine, AI-assisted diagnosis, digital therapy breakthroughs, and capital market interests in technology directions and company profiles [5]. Group 4: Participation and Submission Guidelines - The awards are open to medical device and digital medical technology companies with innovative products or platform technologies that demonstrate originality, advancement, and scalability potential [6]. - Submission for the awards is open until May 31, 2025, with a review phase from June 1 to June 15, 2025, and results to be announced between June 16 and June 22, 2025 [10].

Core Viewpoint - The establishment of the Shenzhen University Medical Engineering Cross-Innovation Research Institute aims to integrate various academic resources to address key technological challenges in the medical equipment industry and cultivate interdisciplinary talent in medical engineering [1][2]. Group 1: Research Institute Overview - The research institute is the first "flexible configuration" institute at Shenzhen University, focusing on high-end medical equipment, intelligent assistive devices, medical big data, and cross-scale diagnostic systems [1]. - The institute aims to create an integrated innovation platform that combines industry, academia, and research to enhance the medical device industry and public health services [1]. Group 2: Leadership and Expertise - The executive director of the research institute is Professor Kuang Shaolong, who has extensive experience in medical robotics and intelligent diagnostic equipment development [2]. - A strategic consulting team led by ten academicians and a technology expert committee comprising 15 authorities in clinical medicine and artificial intelligence will guide the institute's development [1][2]. Group 3: Collaborative Initiatives - The institute has joined various associations to leverage industry resources and promote collaborative research projects, aiming for technology transfer and talent development [2]. - The establishment of the "Medical Engineering Cross-Innovation Alliance" includes partnerships with over 20 research institutions and industry associations to drive market-oriented operations and technology commercialization [3].

Core Viewpoint - The medical technology industry is at a crossroads of breakthrough and reconstruction, with advancements in AI-assisted diagnosis, high-end intelligent diagnostic equipment, innovative medical materials, and regenerative medicine reshaping disease discovery, treatment, and management [1] Group 1: Conference Overview - The Second Global MedTech Conference will be held on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, aiming to promote the collaborative development of the global medical technology industry chain, innovation chain, and clinical application [1][4] - The first conference, Global MedTech Conference 2024, was organized by Siyu [2] Group 2: Awards and Recognition - The conference will present several awards to recognize breakthroughs in medical technology, including the 2025 Global MedTech Innovation Award and the 2025 Global MedTech Clinical Application Award [3][7] - The awards aim to honor innovative products or platform technologies with originality, advancement, and potential for large-scale industrialization [6] Group 3: Conference Agenda - Proposed agenda topics include analysis of global medical technology development trends and policy environments, research and transformation paths for imaging platforms, new consumables, brain-computer interfaces, interventional devices, and diagnostic equipment [5] - Other topics will cover AI-assisted diagnosis, digital therapy breakthroughs, and insights into technology directions and enterprise profiles that attract domestic and foreign capital [5] Group 4: Participation and Submission Process - Companies interested in participating in the awards must fill out a designated form and submit relevant documents by May 31, 2025 [9][10] - The evaluation phase will occur from June 1 to June 15, 2025, with results announced between June 16 and June 22, 2025 [10]

Core Insights - The establishment of the Xi'an Jiaotong University Second Affiliated Hospital Medical Robot Research Center marks the first medical robot research center in Northwest China, aiming to create a national-level innovation platform integrating R&D, verification, and transformation [1][3]. Group 1: Research Center Objectives - The research center will focus on becoming a leader in technological innovation, a benchmark for medical-engineering integration, and a hub for international cooperation, with ten key positioning strategies [4]. - It aims to tackle eight major research directions, including minimally invasive surgical robot technology, intelligent assisted diagnosis navigation, and rehabilitation robot system development, targeting breakthroughs in key technologies such as precision robotic arms and remote operation [4]. Group 2: Collaboration and Development - A strategic cooperation agreement was signed between the medical institution and enterprises, focusing on core goals of joint research, clinical transformation, and industrial collaboration [4]. - The collaboration aims to build a platform for rapid technology R&D and verification, share resources, and cultivate a multidisciplinary medical-engineering team to provide more precise and efficient healthcare services [4]. Group 3: Industry Context - Shaanxi Province has been actively promoting high-quality development in the robotics industry, with a complete industrial chain covering machine manufacturing, key component production, and system application integration [3]. - The establishment of the research center is seen as a significant milestone in the development of medical robots in Shaanxi, further facilitating the transformation of research outcomes into practical applications [3].

Group 1 - The core viewpoint of the articles highlights the establishment of Tsinghua AI Agent Hospital, marking a significant development in the intersection of artificial intelligence and healthcare, aiming to enhance the efficiency and accessibility of high-quality medical services [1] - The AI hospital will initially focus on general medicine and specialized fields such as ophthalmology, radiology, and respiratory medicine, with plans to create an "AI + healthcare + education + research" ecosystem [1] - The application of AI in healthcare is gaining policy support, seen as an effective means to improve diagnostic efficiency and hospital management, with expectations that companies in this sector will benefit from the widespread adoption of AI technology [1] Group 2 - According to Zhongyin Securities, the integration of AI technology in the healthcare sector is accelerating, with multiple hospitals completing relevant deployments [2] - AI optimizes resource allocation in hierarchical diagnosis and treatment, alleviates pressure on large hospitals, enhances health management precision in physical examinations, and reduces costs while improving efficiency in early disease screening [2] - Although medical AI has not yet been widely implemented, its vast application prospects are expected to profoundly change the operational model of the healthcare industry and promote high-quality development [2]

文章来源：骨未来 转载要求：可以直接转载，请在文首注明来源 大会由骨未来、智汇骨、思宇MedTech 主办 ， 中关村联新生物医药产业联盟、北京中关村科学城创新 发展有限公司、启迪之星、中关村创业大街科技服务有限公司、中关村科学城CGT产业孵化中心协办 ， 吸引了来自全国各地的600余位临床专家、科研学者、企业代表和投资人，围绕骨科科技创新、医工交 叉、集采政策、手术机器人等热点话题展开深入交流与讨论。 # 高规格开幕，政府、医院、媒体三方联动 大会开幕式由思宇MedTech创始人、骨未来主编、中关村联新生物医药产业联盟秘书长赵清主持。 开幕式上， 北京市 海淀区副区长 林航 表示， 海淀将以更开放的机制、更精准的服务支持骨科创新，推 动更多像骨科机器人、生物材料这样的好产品从"临床需求"出发、从"海淀出发"，走向全国。 2025年4月24日， 首届全球骨科大会（Global Orthopedics Conference 2025）在北京市中关村自主 创新示范区展示中心隆重举行。 北京市医药健康科技发展中心主任 刘慧 指出， 北京正以"政策牵引+平台建设+三医协同"为抓手，持续强化临床需求导向的科技创新体 系 ...

在帕金森病诊疗领域，臻络科学拥有全球唯一的完整诊疗闭环体系。 本文为IPO早知道原创 作者｜ Stone Jin 微信公众号｜ipozaozhidao 4月8日，在 临近第 29个世界帕金森病日 （ 4月11日） 之际，神经系统疾病领域创新医疗技术企业 「 臻 络 科 学 」 发 布 了 面 向 帕 金 森 病 及 相 关 疾 病 的 全 场 景 医 疗 人 工 智 能 系 统 ——" 智 医 灵 心"（GYENNO Intelligence）。 利用大模型、深度学习、经典机器学习等人工智能技术，智医灵心持续学习领域医学知识和专家经 验，深度挖掘数据规律，并不断自我进化。以不同形态融入各类具身载体中，贯穿院内外全时空场 景，为临床和患者提供帮助。 事实上， 成立于 2013年的 臻络科学 聚焦神经系统疾病领域及数字诊疗已长达 12年，并在 帕金森 病诊疗领域 拥有全球唯一的完整诊疗闭环技术体系 —— 通过创新医疗设备、临床数据平台及慢病管 理平台 ，完成 覆盖 了 诊断、评估、治疗、康复和个性化患者管理 ， 并构建全国最主流帕金森病临 床数据平台 。 截至 目前 ， 臻络科学的设备和软件已覆盖了全国 700多 ...